Surgical options for repair include gastrocnemius V-Y advancement, fascial turndown flaps, and tendon transfers using tendons such as the flexor hallucis longus, flexor digitorum longus, peroneus brevis, gracilis, semitendinosus, and allografts (Malagelada, Clark, and Dega 2016
In the ATTAIN-1 phase 3 clinical trial, participants on the highest dose who remained on treatment lost an average of about 12.4 percent of their body weight approximately 27.3 pounds over 72 weeks, compared to less than 1 percent for those on placebo
It's been developed as a nutraceutical supplement in New Zealand, with over 15 years of research, largely backed by the New Zealand government
Additional information may be obtained when you ask your doctor or pharmacist
That way, if you do experience any side effects that you are concerned about or that are too uncomfortable to handle, you can quickly get in touch with a provider for medical advice